Trump Announces ‘Historical Breakthrough’ as US Approves Plasma Treatment for COVID-19

Reading Time: < 1 minute

SWITZERLAND, AUGUST 24 – The United States Food and Drugs Administration (FDA) has granted emergency approval of blood plasma from recovered coronavirus patients as a treatment for those battling the disease. President Donald Trump called the development “a historic breakthrough.”

US President Donald Trump late on Sunday announced emergency authorization to treat those suffering from the coronavirus with convalescent plasma, a move he described as “a historic breakthrough.”

One of his top health officials said it was a “promising” development, but other experts have cautioned that the treatment needs further evaluation before it should be celebrated.

Trump’s declaration came after White House officials suggested there were politically motivated delays by the FDA in approving treatments for the novel coronavirus.

The emergency approval makes it easier for some to get the treatment, but is not the same as full FDA authorization.

The blood plasma, taken from patients who have recovered from COVID-19 and have plenty of antibodies, may give benefits to those fighting the virus. But the evidence so far has been inconclusive over its effectiveness, when to administer it and what dosage is required.

In a letter referring to the approval, FDA chief scientist Denise Hinton said: “COVID-19 convalescent plasma should not be considered a new standard of care for the treatment of patients with COVID-19. Additional data will be forthcoming from other analyses and ongoing, well-controlled clinical trials in the coming months.”

Leave a Reply

%d bloggers like this: